Email still works. If it reaches the right doctor, with the right content.
The problem is not the channel. It is the list, the content and the timing.
Why email remains the most direct channel to the doctor.
In pharmaceutical marketing email is not an old channel: it is the only one that reaches the doctor in a direct, personal and measurable way, without depending on third-party platform algorithms. But it works on one condition: that the address is certified, profiled and consented, and that the content is worth opening.
A DEM sent to a purchased list, not profiled and without consent, is not marketing: it is waste and regulatory risk. The difference between a campaign that generates engagement and one that ends up in spam lies entirely upstream — in the quality of the database and the relevance of the message.
Merqurio sends DEM and email marketing on proprietary, certified and profiled lists, with content built for the medical target.
A dedicated email send, separate from editorial publications, with a branded and personalised message and 2-3 calls to action toward an in-depth piece on DottNet or an external link. It serves when you need a communication exclusively dedicated to the product, with full flexibility of target, date, time and subject.
A promotional ad with a branded message, delivered through a sector news publication. It intercepts the reader inside an editorial experience, when the objective is visibility and brand value rather than the product message alone.
Every send starts from the proprietary database: segmentation by specialisation, therapeutic area, interests and behaviours, enriched with DottNet browsing data.
Opens, clicks, content consumed, conversions: every campaign is tracked and feeds the next one.
The Classic DEM brings branded content directly to the doctor, without editorial distractions.
The Integrated DEM places your message in a publication the doctor already reads.
Database profiling makes it possible to select exactly the right specialisation and profile.
The DEM coordinates with DottNet, social and the Informatore Remoto® on the same message.
The quality of an email campaign does not depend on the sending tool, but on the list and the content. Merqurio owns both.
The database counts over 300,000 healthcare professionals — of which 250,000 doctors — profiled, updated with over 2,000 daily changes, GDPR compliant and activatable for targeted sends. The emails are collected with consent over time, not purchased. To this is added the in-house editorial capacity to produce the scientific content that makes an email worth opening, and the DottNet channel — 250,000 subscribers, 100,000 weekly unique readers — as the natural destination for in-depth content.
